Green Cross LabCell

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 1, 2021	Artiva Biotherapeutics	$120.0M Series B	Venrock	5AM Ventures, Frazier Healthcare Partners, RA Capital, venBio, Acuta Capital Partners, Cormorant Asset Management, EcoR1 Capital, Franklin Templeton, Green Cross Holdings, Janus Henderson Investors, Logos Capital, RA Capital Management, RTW Investments, Surveyor Capital, Wellington Management

Total Raised

N/A

Valuation

N/A